Status:
COMPLETED
Drug Use Evaluation of Clindamycin in Critical Care Units in Alexandria Main University Hospital
Lead Sponsor:
Alexandria University
Conditions:
Infection, Bacterial
Eligibility:
All Genders
18-100 years
Brief Summary
Irrational use of antibiotics is a one of the main health system problems,it leads to antibiotic resistance,increasing antibiotics side effects and the total cost. This study is a medication use evalu...
Eligibility Criteria
Inclusion
- Adults 18 years old or more .
- Patients on clindamycin as an empirical treatment.
- Patients started clindamycin as an emperical treatment in other departments but the physician approved to continue it in critical care.
Exclusion
- Children (less than 18 years old)
- Patients started clindamycin as a defenitive treatment (based on microbiological culture results).
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT05223400
Start Date
March 1 2022
End Date
April 1 2022
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Mdicine
Alexandria, Egypt